Cargando…

Research Progress and Prospect of Nanoplatforms for Treatment of Oral Cancer

Oral cancers refer to malignant tumors associated with high morbidity and mortality, and oral squamous cell carcinoma accounts for the majority of cases. It is an important part of head and neck, and oral cancer is one of the six most common cancers in the world. At present, the traditional treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zhilong, Li, Dan, Wu, Ziqi, Wang, Qihui, Ma, Zhangyu, Zhang, Congxiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773899/
https://www.ncbi.nlm.nih.gov/pubmed/33391000
http://dx.doi.org/10.3389/fphar.2020.616101
_version_ 1783630148103307264
author Zhao, Zhilong
Li, Dan
Wu, Ziqi
Wang, Qihui
Ma, Zhangyu
Zhang, Congxiao
author_facet Zhao, Zhilong
Li, Dan
Wu, Ziqi
Wang, Qihui
Ma, Zhangyu
Zhang, Congxiao
author_sort Zhao, Zhilong
collection PubMed
description Oral cancers refer to malignant tumors associated with high morbidity and mortality, and oral squamous cell carcinoma accounts for the majority of cases. It is an important part of head and neck, and oral cancer is one of the six most common cancers in the world. At present, the traditional treatment methods for oral cancer include surgery, radiation therapy, and chemotherapy. However, these methods have many disadvantages. In recent years, nanomedicine, the delivery of drugs through nanoplatforms for the treatment of cancer, has become a promising substitutive therapy. The use of nanoplatforms can reduce the degradation of the drug in the body and accurately deliver it to the tumor site. This minimizes the distribution of the drug to other organs, thereby reducing its toxicity and allowing higher drug concentration at the tumor site. This review introduces polymer nanoparticles, lipid-based nanoparticles, metal nanoparticles, hydrogels, exosomes, and dendrimers for the treatment of oral cancer, and discusses how these nanoplatforms play an anti-cancer effect. Finally, the review gives a slight outlook on the future prospects of nanoplatforms for oral cancer treatment.
format Online
Article
Text
id pubmed-7773899
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-77738992021-01-01 Research Progress and Prospect of Nanoplatforms for Treatment of Oral Cancer Zhao, Zhilong Li, Dan Wu, Ziqi Wang, Qihui Ma, Zhangyu Zhang, Congxiao Front Pharmacol Pharmacology Oral cancers refer to malignant tumors associated with high morbidity and mortality, and oral squamous cell carcinoma accounts for the majority of cases. It is an important part of head and neck, and oral cancer is one of the six most common cancers in the world. At present, the traditional treatment methods for oral cancer include surgery, radiation therapy, and chemotherapy. However, these methods have many disadvantages. In recent years, nanomedicine, the delivery of drugs through nanoplatforms for the treatment of cancer, has become a promising substitutive therapy. The use of nanoplatforms can reduce the degradation of the drug in the body and accurately deliver it to the tumor site. This minimizes the distribution of the drug to other organs, thereby reducing its toxicity and allowing higher drug concentration at the tumor site. This review introduces polymer nanoparticles, lipid-based nanoparticles, metal nanoparticles, hydrogels, exosomes, and dendrimers for the treatment of oral cancer, and discusses how these nanoplatforms play an anti-cancer effect. Finally, the review gives a slight outlook on the future prospects of nanoplatforms for oral cancer treatment. Frontiers Media S.A. 2020-12-17 /pmc/articles/PMC7773899/ /pubmed/33391000 http://dx.doi.org/10.3389/fphar.2020.616101 Text en Copyright © 2020 Zhao, Li, Wu, Wang, Ma and Zhang http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zhao, Zhilong
Li, Dan
Wu, Ziqi
Wang, Qihui
Ma, Zhangyu
Zhang, Congxiao
Research Progress and Prospect of Nanoplatforms for Treatment of Oral Cancer
title Research Progress and Prospect of Nanoplatforms for Treatment of Oral Cancer
title_full Research Progress and Prospect of Nanoplatforms for Treatment of Oral Cancer
title_fullStr Research Progress and Prospect of Nanoplatforms for Treatment of Oral Cancer
title_full_unstemmed Research Progress and Prospect of Nanoplatforms for Treatment of Oral Cancer
title_short Research Progress and Prospect of Nanoplatforms for Treatment of Oral Cancer
title_sort research progress and prospect of nanoplatforms for treatment of oral cancer
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773899/
https://www.ncbi.nlm.nih.gov/pubmed/33391000
http://dx.doi.org/10.3389/fphar.2020.616101
work_keys_str_mv AT zhaozhilong researchprogressandprospectofnanoplatformsfortreatmentoforalcancer
AT lidan researchprogressandprospectofnanoplatformsfortreatmentoforalcancer
AT wuziqi researchprogressandprospectofnanoplatformsfortreatmentoforalcancer
AT wangqihui researchprogressandprospectofnanoplatformsfortreatmentoforalcancer
AT mazhangyu researchprogressandprospectofnanoplatformsfortreatmentoforalcancer
AT zhangcongxiao researchprogressandprospectofnanoplatformsfortreatmentoforalcancer